The DreamLab app, developed by Vodafone Foundation and Imperial College London, has completed Phase 3 of its cancer-related DRUGS - Drug Repositioning Using Grids of Smartphones - project.
DRUGS Phase 3 is the largest research project ever undertaken looking into whether combinations of pre-existing drugs might be better at treating specific forms of cancer.
By harnessing the collective computing power of tens of thousands of smartphones being charged overnight, Imperial College researchers have been able to trawl through masses of scientific data looking for the best drug combinations.
This builds upon the first two phases of DRUGS which examined the anti-cancer potential of single drugs and foods respectively.
These previous phases have already led to promising new discoveries: hundreds of anti-cancer molecules exist in everyday foods such as oranges, cabbages and grapes, for example, and two existing drugs designed for treating other conditions also have anti-cancer properties.
Researchers at Imperial College London now have to analyse all the Phase 3 results in detail.